The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
SB‐334867‐A: the first selective orexin‐1 receptor antagonist
Open accessAbstract
The pharmacology of various peptide and non‐peptide ligands was studied in Chinese hamster ovary (CHO) cells stably expressing human orexin‐1 (OX 1) or orexin‐2 (OX 2) receptors by measuring intracellular calcium ([Ca 2+]i) using Fluo‐3AM. Orexin‐A and orexin‐B increased [Ca 2+]i in CHO‐OX 1 (pEC 50=8.38±0.04 and 7.26±0.05 respectively, n=12) and CHO‐OX 2 (pEC 50=8.20±0.03 and 8.26±0.04 respectively, n=8) cells. However, neuropeptide Y and secretin (10 p M – 10 μ M) displayed neither agonist nor antagonist properties in either cell‐line. SB‐334867‐A (1‐(2‐Methyylbenzoxanzol‐6‐yl)‐3‐[1,5]naphthyridin‐4‐yl‐urea hydrochloride) inhibited the orexin‐A (10 n M) and orexin‐B (100 n M)‐induced calcium responses (p KB=7.27±0.04 and 7.23±0.03 respectively, n=8), but had no effect on the UTP (3 μ M)‐induced calcium response in CHO‐OX 1 cells. SB‐334867‐A (10 μ M) also inhibited OX 2 mediated calcium responses (32.7±1.9% versus orexin‐A). SB‐334867‐A was devoid of agonist properties in either cell‐line. In conclusion, SB‐334867‐A is a non‐peptide OX 1 selective receptor antagonist. British Journal of Pharmacology (2001) 132, 1179–1182; doi:10.1038/sj.bjp.0703953
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
van den Pol, A. N., Gao, X.-B., Obrietan, K., Kilduff, T. S., & Belousov, A. B. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07962.1998 · Cited by 552
Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord
van den Pol, A. N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03171.1999 · Cited by 526
The novel brain neuropeptide, orexin‐A, modulates the sleep–wake cycle of rats
Piper, D. C., Upton, N., Smith, M. I., & Hunter, A. J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00919.x · Cited by 351
Smart, D., Jerman, J. C., Brough, S. J., Rushton, S. L., Murdock, P. R., Jewitt, F., Elshourbagy, N. A., Ellis, C. E., Middlemiss, D. N., & Brown, F. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702780 · Cited by 188
Self-citationThe physiology and pharmacology of the orexins
Smart, D., & Jerman, J. C. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00171-7 · Cited by 100
Self-citationSensitivity of Orexin-A Binding to Phospholipase C Inhibitors, Neuropeptide Y, and Secretin
Kane, J. K., Tanaka, H., Parker, S. L., Yanagisawa, M., & Li, M. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2880 · Cited by 36
Cited by
Pathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998
Neural substrates of awakening probed with optogenetic control of hypocretin neurons
Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K., & de Lecea, L. (2007) · Nature · doi:10.1038/nature06310 · Cited by 1,341
A role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311
Orexin Receptors: Pharmacology and Therapeutic Opportunities
Scammell, T. E., & Winrow, C. J. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100528 · Cited by 381
Goadsby, P. J., Charbit, A. R., Andreou, A. P., Akerman, S., & Holland, P. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.019 · Cited by 371
Metadata
- Authors
- Smart, D., Sabido‐David, C., Brough, S. J., Jewitt, F., Johns, A., Porter, R. A., & Jerman, J. C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2001-03
- Volume
- 132
- Issue
- 6
- Pages
- 1179-1182
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2130717252
- Cited by
- 308
- References
- 8
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SB‐334867‐A: the first selective orexin‐1 receptor antagonist. https://app.cochat.ai/papers/10.1038/sj.bjp.0703953
- The paper
- Smart, D., Sabido‐David, C., Brough, S. J., Jewitt, F., Johns, A., Porter, R. A., & Jerman, J. C. (2001). SB‐334867‐A: the first selective orexin‐1 receptor antagonist. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0703953
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.